|
|
| | LY-573636 Basic information |
| Product Name: | LY-573636 | | Synonyms: | LY 573636Na;N-[(5-Bromo-2-thienyl)sulfonyl]-2,4-dichlorobenzamide sodium salt;Tasisulam sodium;Tasisulam Sodium (LY573636);CS-881;LY-573636 ISO 9001：2015 REACH;Tasisulam sodium (LY 573636 sodium) | | CAS: | 519055-63-1 | | MF: | C11H5BrCl2NNaO3S2 | | MW: | 437.09207 | | EINECS: | | | Product Categories: | | | Mol File: | 519055-63-1.mol |  |
| | LY-573636 Chemical Properties |
| | LY-573636 Usage And Synthesis |
| Uses | Tasisulam is a anticancer agent and induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death. Tasisulam inhibits mitotic progression and induces vascular normalization[1]. | | References | [1] Meier T, et al. Tasisulam sodium, an antitumor agent that inhibits mitotic progression and induces vascular normalization. Mol Cancer Ther. 2011 Nov;10(11):2168-78. DOI:10.1158/1535-7163.MCT-11-0323 |
| | LY-573636 Preparation Products And Raw materials |
|